Scilex Holding Co (SCLX) stock
SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$2.57−0.26 (-9.19%)
Close on Oct 19, 2026Market cap $17.71MP/E –Yield –
Scilex free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Scilex's free cash flow for the twelve months ending Dec 31, 2024 was $19.35M. For fiscal 2025 it was $3.68M, down 81.0% from the year before. The highest annual figure on record is $19.35M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.68M | -81.0% |
| FY2024 | Dec 31, 2024 | $19.35M | – |
| FY2023 | Dec 31, 2023 | -$20.74M | – |
| FY2022 | Dec 31, 2022 | -$21.27M | – |
| FY2021 | Dec 31, 2021 | -$28.66M | – |
| FY2020 | Dec 31, 2020 | -$31.49M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $2.53M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.11M | +102.4% |
| Q4 FY2023 | Dec 31, 2023 | -$5.39M | – |
| Q3 FY2023 | Sep 30, 2023 | $5.88M | – |
| Q4 FY2022 | Dec 31, 2022 | -$725.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $2.53M | – |
See a number that looks wrong?